Alzheimer's disease (AD) and COVID-19 share many common risk factors, such as
advanced age, complications, APOE genotype, etc. Epidemiological studies have also …

BackgroundPeople with neurodegenerative disease and mild cognitive impairment (MCI)
may have an elevated risk of acquiring severe acute respiratory syndrome coronavirus 2 …

In the era of a steadily increasing lifespan, neurodegenerative diseases among the elderly
present a significant therapeutic and socio-economic challenge. A properly balanced diet …

Objectives To undertake a systematic review and meta-analysis to estimate the relative risk
of COVID-19-related mortality among people with disabilities compared to people without …

Objectives: This study aims to investigate the risk factors associated with severity and death
from COVID-19 through a systematic review and meta-analysis of the published documents …

Objectives Despite the numerous studies on coronavirus disease 2019 (COVID-19), data
regarding the impact of pre-existing diagnoses of Alzheimer's disease (AD) and Parkinson's …

This review is conducted against the background of nanotechnology, which provides us with
a chance to effectively combat the spread of coronaviruses, and which primarily concerns …

Patients with Parkinson's disease (PD) and coronavirus disease 2019 (COVID‑19)‑
associated pneumonia present, according to the literature, high mortality rates due to the …

Background: The identification of risk factors for SARS-CoV-2 infection and mortality in
patients with dementia is a key aspect to support clinical decisions and public health …

Background Parkinson's disease has been identified as a risk factor for severe Coronavirus
disease 2019 (COVID-19) outcomes. However, whether the significant high risk of death …